..News out !!!!!
ORIGINAL: Correction - Relay Medical announces completion of HemoPalm(TM) Proof-of-Principle CO-oximeter Prototype, a Proprietary, State-of-the-Art, Point-of-Care Technology 2020-02-25 16:55 ET - News Release Toronto, Ontario--(Newsfile Corp. - February 25, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company") , a developer of MedTech innovation, is pleased to announce the completion of the HemoPalm-CX, a proof-of-principle prototype compact POCT instrument that directly measures five CO-oximetry components from human whole blood. The system uses proprietary optics and data analysis technology developed by the Company's HemoPalm diagnostics division. This correction is being issued to fix a typo in the headline where HemoPal(TM) should have read HemoPalm(TM). The corrected release in its entirety is being issued below. https://www.stockwatch.com/News/Item?bid=Z-C%3aRELA-2869955&symbol=RELA®ion=C